Received May 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | AHBVB767BA | — |
Engerix-b possible expired dose administration; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a female patient who received HBV (Engerix B) (batch number AHBVB767BA) for prophylaxis. On 31-DEC-2009, the patient received Engerix B. On 31-DEC-2009, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: Engerix-b possible expired dose administration). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 20-MAY-2025 Registered nurse wanted to know the expiration date of an Engerix-B that was administered in 2009 given that their system flagged that the vaccine was expired when it was applied which led to expired vaccine use. The Medical Information agent tried to find it through the lot number provided, but had no luck, thus transferred to the Vaccine Service Center was effectuated. The Medical Information agent could catch in their call while leaving after introducing both parts that the expiration date of the product provided by the Vaccine Service Center agent was in 2010, but still made the adverse event report given that the health care provider mentioned that she was not sure that they had the real date of administration because they don't administer vaccines at the end of the year.